Exact Sciences Corporation
EXAS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10,355 | $10,038 | $8,087 | $10,413 |
| - Cash | $789 | $657 | $347 | $601 |
| + Debt | $2,521 | $2,521 | $2,521 | $2,755 |
| Enterprise Value | $12,087 | $11,903 | $10,261 | $12,567 |
| Revenue | $851 | $811 | $707 | $713 |
| % Growth | 4.9% | 14.8% | -0.9% | – |
| Gross Profit | $584 | $562 | $501 | $429 |
| % Margin | 68.6% | 69.3% | 70.8% | 60.2% |
| EBITDA | $38 | $53 | -$38 | -$815 |
| % Margin | 4.5% | 6.6% | -5.4% | -114.2% |
| Net Income | -$20 | -$1 | -$101 | -$865 |
| % Margin | -2.3% | -0.1% | -14.3% | -121.2% |
| EPS Diluted | -0.1 | -0.006 | -0.54 | -4.67 |
| % Growth | -1,487.3% | 98.8% | 88.4% | – |
| Operating Cash Flow | $220 | $89 | $31 | $47 |
| Capital Expenditures | -$30 | -$42 | -$31 | -$36 |
| Free Cash Flow | $190 | $47 | -$0 | $11 |